Examples of using Quantitative composition in English and their translations into Slovak
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Qualitative and quantitative composition of impurities.
The International Union for Conservation of Nature(IUCN)classifies medical leeches as animals with a vulnerable quantitative composition.
In the future, when the qualitative and quantitative composition of the intestinal microflora is changed, intestinal dysbiosis can occur.
Its parts/components(including software if appropriate), its formulation, its composition, itsfunctionality and, where relevant, its qualitative and quantitative composition.
The normal flora should contain lactobacilli in the quantitative composition of not less than 10x7.
The quantitative composition of substances and their ratios in the compounds is devoted to a separate section of chemistry, called stoichiometry.
The composition of breast milk directly depends on the qualitative and quantitative composition of the daily diet of a lactating woman.
Qualitative and quantitative composition in terms of the active substances and non-active substances, knowledge of which is essential for proper use of the biocidal product;
(c) where intended for administration to food-producing animals,the veterinary medicinal products have the same qualitative and quantitative composition of active substances as the veterinary medicinal products authorised in the host Member State;
Qualitative and quantitative composition in terms of the active substances and constituents of the excipient, knowledge of which is essential for proper administration of the medicinal product;
(c) the veterinary medicinal products intended for administration tofood-producing animals have the same qualitative and quantitative composition in terms of active substances as the medicinal products authorized in accordance with Articles 5, 7 and 8 in the host Member State;
The competent authorities shall suspend, revoke or vary a marketing authorisation if the view is taken that the medicinal product is harmful or lacks therapeutic efficacy,that the risk-benefit balance is not favourable or that its qualitative and quantitative composition is not as declared.
The particular elements of the qualitative and quantitative composition or the special manufacturing process which gives the product its particular nutritional characteristics;
The competent authorities shall suspend, revoke, withdraw or vary a marketing authorisation if the view is taken that the product is harmful or that it lacks therapeutic efficacy, or that the risk-benefit balance is not positive,or that its qualitative and quantitative composition is not as declared.
Description of the qualitative and quantitative composition of the product, including chemical identity of the substances(incl. chemical name, INCI, CAS, EINECS/ELINCS) and their intended function.
The competent authorities of the Member States shall suspend or revoke an authorisation to place a proprietary medicinal product on the market where that product proves to be harmful in the normal conditions of use, or where its therapeutic efficacy is lacking,or where its qualitative and quantitative composition is not as declared.
Specific character may not be restricted to qualitative or quantitative composition or to a mode of production laid down in Community or national legislation, in standards set by standardization bodies or in voluntary standards;
Within the meaning of Article 5(1), the normal viable colony count of natural mineral water means the reasonably constant total colony count at source before any treatment,whose qualitative and quantitative composition taken into account in the recognition of that water is checked by periodic analysis.
Specific character may not be restricted to qualitative or quantitative composition or to a mode of production laid down in Community or national legislation, in standards set by standardization bodies or in voluntary standards;
Following the granting of a marketing authorisation, the authorisation holder may allow use to be made of the pharmaceutical, pre-clinical and clinical documentation contained in the file on the medicinal product, with a view to examining subsequent applications relating to othermedicinal products possessing the same qualitative and quantitative composition in terms of active substances and the same pharmaceutical form.
The specific characteristic defined in paragraph 1(a) may not be restricted to qualitative or quantitative composition, or to a mode of production, laid down in Community or national legislation, in standards set by standardisation bodies or in voluntary standards;
For the purposes of determining qualitative and quantitative composition of the active substances, different salts, esters, ethers, isomers, mixtures of isomers, complexes and derivatives of an active substance shall be considered to be the same active substance, unless they differ significantly in properties with regard to safety or efficacy.
Applications for generic veterinary medicinal products shall contain the documentation referred to in Annex I, quality data anddata demonstrating that the product has the same qualitative and quantitative composition in active substances and the same pharmaceutical form as the reference medicinal product and data showing bio- equivalence with the reference medicinal product.
(27a)‘essentially similar product‘ means a generic product thatsatisfies the criteria of having the same qualitative and quantitative composition in terms of active substances, of having the same pharmaceutical form, and of being bioequivalent to the original product, unless it is apparent in the light of scientific knowledge that it differs from the original product as regards safety and efficacy;
A harmonised summary of product characteristics shall be prepared in accordance with the procedure laid down in Article 69 for veterinary medicinal products, other than homeopathic veterinary medicinal products,which have the same qualitative and quantitative composition of their active substances and the same pharmaceutical form and for which national marketing authorisations have been granted in different Member States before 1 January 2004(‘similar products').
The specific characteristic defined in paragraph 1(a)may not be restricted to qualitative or quantitative composition, or to a mode of production, laid down in Community or national legislation, in standards set by standardisation bodies or in voluntary standards;
A medicinal product is essentially similar to an original product where itsatisfies the criteria of having the same qualitative and quantitative composition in terms of active substances, of having the same pharmaceutical form, and of being bioequivalent unless it is apparent in the light of scientific knowledge that it differs from the original product as regards safety and efficacy.
A medicinal product is essentially similar to an original medicinal product where itsatisfies the cri-teria of having the same qualitative and quantitative composition in terms of active principles, of having the same pharmaceutical form and of being bio-equivalent, unless it is apparent in the light of scientific knowledge that it differs significantly from the original product as regards safety or efficacy.